Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Ullamari, Pesonen"'
Autor:
Sammeli Liikkanen, Janne Sinkkonen, Joni Suorsa, Valtteri Kaasinen, Eero Pekkonen, Mikko Kärppä, Filip Scheperjans, Teppo Huttunen, Toni Sarapohja, Ullamari Pesonen, Mikko Kuoppamäki, Tapani Keränen
Publikováno v:
PLOS Digital Health, Vol 2, Iss 4, p e0000225 (2023)
In the quantification of symptoms of Parkinson's disease (PD), healthcare professional assessments, patient reported outcomes (PRO), and medical device grade wearables are currently used. Recently, also commercially available smartphones and wearable
Externí odkaz:
https://doaj.org/article/012d6c5856004986a94efd8d4883e5a0
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 4, Pp n/a-n/a (2021)
Abstract α2‐Adrenoceptor agonists such as clonidine and dexmedetomidine are used as adjuvants to local anesthetics in regional anesthesia. Fadolmidine is an α2‐adrenoceptor agonist developed especially as a spinal analgesic. The current studies
Externí odkaz:
https://doaj.org/article/03043c47ea0f4626a0455857cd6103e5
Autor:
Jyrki, Lehtimäki, Niina, Jalava, Kaisa, Unkila, John, Aspegren, Antti, Haapalinna, Ullamari, Pesonen
Publikováno v:
European journal of pharmacology. 923
The pharmacological profile of tasipimidine, a novel orally active α
Autor:
Henriikka Salomäki-Myftari, Laura H Vähätalo, Liisa Ailanen, Sami Pietilä, Asta Laiho, Arno Hänninen, Juha-Pekka Pursiheimo, Eveliina Munukka, Anniina Rintala, Eriika Savontaus, Ullamari Pesonen, Markku Koulu
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163805 (2016)
Prenatal metformin exposure has been shown to improve the metabolic outcome in the offspring of high fat diet fed dams. However, if this is evident also in a genetic model of obesity and whether gut microbiota has a role, is not known.The metabolic e
Externí odkaz:
https://doaj.org/article/9bf86201797f4bf58d8875ad9cd37f3c
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 16, Iss 9, Pp 569-576 (2012)
Neuropeptide Y (NPY) is a neuropeptide widely expressed in the brain and a peptide transmitter of sympathetic nervous system (SNS) co-released with noradrenaline (NA) in prolonged stress. Association of a gain-of-function polymorphism in the human NP
Externí odkaz:
https://doaj.org/article/6320d985396c4912820bd99120fa4bdb
Autor:
Marina Kolkka, Satu K. Jääskeläinen, Heli Forssell, Arja Virtanen, Antti Puhakka, Ullamari Pesonen
Publikováno v:
European Journal of Pain. 23:1153-1161
BACKGROUND AND AIMS Neuropathic mechanisms are involved in burning mouth syndrome (BMS), and variation of the dopamine D2 receptor (DRD2) gene contributes to experimental pain perception. We investigated whether neurophysiologic findings differ in BM
Autor:
Henriikka Salomäki, Merja Heinäniemi, Laura H Vähätalo, Liisa Ailanen, Kim Eerola, Suvi T Ruohonen, Ullamari Pesonen, Markku Koulu
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115778 (2014)
AIMS: Despite the wide use of metformin in metabolically challenged pregnancies, the long-term effects on the metabolism of the offspring are not known. We studied the long-term effects of prenatal metformin exposure during metabolically challenged p
Externí odkaz:
https://doaj.org/article/20a301e0e5534513a7ee092d49598223
Autor:
Esa Kauppila, Esko Vanninen, Salla Kaurijoki, Leila Karhunen, Kirsi H Pietiläinen, Aila Rissanen, Jari Tiihonen, Ullamari Pesonen, Jaakko Kaprio
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e50303 (2013)
ObjectiveSerotonin transporter gene polymorphism (5-HTTLPR polymorphism) predicts the degree of structural and functional connectivity in the brain, and less consistently the degree of vulnerability for anxiety and depressive disorders. It is less kn
Externí odkaz:
https://doaj.org/article/3f11307c9e0348ec88766734b32b2df4
Autor:
Henriikka Salomäki, Laura H. Vähätalo, Kirsti Laurila, Norma T. Jäppinen, Anna-Maija Penttinen, Liisa Ailanen, Juan Ilyasizadeh, Ullamari Pesonen, Markku Koulu
Publikováno v:
PLoS ONE, Vol 8, Iss 10 (2013)
Externí odkaz:
https://doaj.org/article/738516bf30d1464e9dfa6ef3a31cd1f5
Autor:
Henriikka Salomäki, Laura H Vähätalo, Kirsti Laurila, Norma T Jäppinen, Anna-Maija Penttinen, Liisa Ailanen, Juan Ilyasizadeh, Ullamari Pesonen, Markku Koulu
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56594 (2013)
AIMS: The antidiabetic drug metformin is currently used prior and during pregnancy for polycystic ovary syndrome, as well as during gestational diabetes mellitus. We investigated the effects of prenatal metformin exposure on the metabolic phenotype o
Externí odkaz:
https://doaj.org/article/9357303844824bc98ca8dfa735fc3a2c